Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in Taiwan
碩士 === 臺北醫學大學 === 藥學研究所 === 96 === Background： Antiplatelet agents can prevent recurrent stroke. Aspirin is the most widely studied one and, until recently, it was the only drug used broadly for this purpose. Now, clinical trials indicate that ticlopidine, clopidogrel, and a combination regimen, asp...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/69272776287261887291 |